ALSO NOTED: Perrigo, Teva get clearance for generic Zyrtec-D; Pfizer sues Impax over copycat Detrol;

> Perrigo and its partner Teva Pharmaceutical Industries got the FDA nod for their over-the-counter version of McNeil Consumer Healthcare's Zyrtec-D; McNeil, a Johnson & Johnson unit, launched its OTC version in January. Report

> Pfizer sued Impax Laboratories over the latter's plans to launch a generic competitor to the overactive-bladder med Detrol LA. Report

> A Connecticut bill that would limit drug makers' gifts to doctors is languishing in the state legislature. Report

> APP Pharmaceuticals reported a 70 percent drop in fourth-quarter profits to $8.5 million on revenues of $194.6 million. Report

Most popular article this week: Schering-Plough slashes jobs. Report

And Finally... Even fictional drugs can cause controversy, as a British TV drama discovered the hard way. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.